Your browser doesn't support javascript.
loading
Prospective long-term follow-up after first-line subcutaneous cladribine in hairy cell leukemia: a SAKK trial.
Benz, Rudolf; Arn, Kornelius; Andres, Martin; Pabst, Thomas; Baumann, Michael; Novak, Urban; Hitz, Felicitas; Hess, Urs; Zenhaeusern, Reinhard; Chalandon, Yves; Mey, Ulrich; Blum, Sabine; Rauch, Daniel; O'Meara Stern, Alix; Cantoni, Nathan; Bargetzi, Mario; Bianchi-Papina, Elena; Rossi, Davide; Passweg, Jakob; Lohri, Andreas; Berardi, Simona; Li, Qiyu; Feller, Anita; Stussi, Georg.
Afiliação
  • Benz R; Division of Hematology and Oncology, Kantonsspital Muensterlingen, Muensterlingen, Switzerland.
  • Arn K; Department of Hematology, Kantonsspital Luzern, Luzern, Switzerland.
  • Andres M; Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Pabst T; Department of Medical Oncology, Inselspital Bern, Bern, Switzerland.
  • Baumann M; Center for Laboratory Medicine St. Gallen, St. Gallen, Switzerland.
  • Novak U; Department of Medical Oncology, Inselspital Bern, Bern, Switzerland.
  • Hitz F; Department of Oncology, Kantonsspital St. Gallen, St. Gallen, Switzerland.
  • Hess U; Department of Oncology, Kantonsspital St. Gallen, St. Gallen, Switzerland.
  • Zenhaeusern R; Department of Oncology Spitalzentrum Oberwallis, Brig, Switzerland.
  • Chalandon Y; Hematology Division, University Hospital Geneva and Faculty of Medicine, University of Geneva, Geneva, Switzerland.
  • Mey U; Oncology and Hematology, Kantonsspital Graubuenden, Graubuenden, Switzerland.
  • Blum S; Service of Hematology, University Hospital Lausanne, Lausanne, Switzerland.
  • Rauch D; Department of Oncology, Spital Thun, Thun, Switzerland.
  • O'Meara Stern A; Department of Oncology, Kantonsspital Neuchatel, Neuchatel, Switzerland.
  • Cantoni N; Division of Hematology and Transfusionmedicine, Kantonsspital Aarau, Aarau, Switzerland.
  • Bargetzi M; Division of Hematology and Transfusionmedicine, Kantonsspital Aarau, Aarau, Switzerland.
  • Bianchi-Papina E; Department of Hematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
  • Rossi D; Department of Hematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
  • Passweg J; Department of Hematology, University Hospital Basel, Basel, Switzerland.
  • Lohri A; Department of Oncology, Kantonsspital Baselland Liestal, Liestal, Switzerland.
  • Berardi S; Swiss Group for Clinical Cancer Research (SAKK) Coordinating Center, Bern, Switzerland; and.
  • Li Q; Swiss Group for Clinical Cancer Research (SAKK) Coordinating Center, Bern, Switzerland; and.
  • Feller A; Foundation National Institute for Cancer Epidemiology and Registration, University of Zurich, Zurich, Switzerland.
  • Stussi G; Department of Hematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
Blood Adv ; 4(15): 3699-3707, 2020 08 11.
Article em En | MEDLINE | ID: mdl-32777066

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Leucemia Base de dados: MEDLINE Assunto principal: Leucemia de Células Pilosas / Antineoplásicos Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Child, preschool / Humans Idioma: En Revista: Blood Adv Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Suíça

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Leucemia Base de dados: MEDLINE Assunto principal: Leucemia de Células Pilosas / Antineoplásicos Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Child, preschool / Humans Idioma: En Revista: Blood Adv Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Suíça